What is the ticker symbol for Oncorus?

Oncorus trades under the ticker ONCR on NASDAQ.

What sector does Oncorus operate in?

Oncorus is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ONCR in a portfolio?

PortView shows ONCR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Oncorus (ONCR) Stock Analysis

NASDAQHealthcareBiotechnology

$0.13-3.08%

1-year price historyRange $0.01 – $0.45

52-week range$0.13

$0.01$0.47

What Oncorus does

Oncorus, Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering viral immunotherapies designed to combat cancer in patients. At the forefront of its pipeline is ONCR-177, an innovative viral immunotherapy that leverages a modified herpes simplex virus type 1 (oHSV-1) platform. This candidate, administered directly into tumors, is presently undergoing Phase I clinical evaluation for a range of different cancers. Beyond this, Oncorus is advancing ONCR-GBM, an oHSV program in preclinical development targeting brain cancer via intratumoral injection. Further research includes synthetic viral immunotherapies derived from Coxsackievirus A21 and Seneca Valley Virus. In a significant collaboration, Oncorus has partnered with MSD International GmbH (Merck) through a clinical trial and supply agreement. This partnership aims to assess the safety and tolerability of ONCR-177 when administered in combination with Merck's well-known cancer immunotherapy, KEYTRUDA, during a Phase I clinical trial involving patients with solid tumors. Established in 2015, Oncorus, Inc. maintains its headquarters in Cambridge, Massachusetts.

Key metrics

Market cap

P/E (TTM)

-0.04

EPS (TTM)

$-3.48

Beta

1.95

Dividend yield

110.58%

Revenue / share

$0.00

50-day avg

$0.03

200-day avg

$0.10

52-week high

$0.47

52-week low

$0.01

CEO

Craig R. Jalbert CIRA

ETFs linked to ONCR

Broad-market and Healthcare sector ETFs an investor holding Oncorus is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ONCR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ONCR in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Oncorus?: Oncorus trades under the ticker ONCR on NASDAQ.
Which exchange is ONCR listed on?: ONCR is listed on NASDAQ.
What sector does Oncorus operate in?: Oncorus is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ONCR in a portfolio?: PortView shows ONCR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.